User profiles for Rafael Blesa

Rafael Blesa Gonzalez

Servicio de Neurología - Hospital St Pau Barcelona
Verified email at santpau.cat
Cited by 16938

[HTML][HTML] New insights into the genetic etiology of Alzheimer's disease and related dementias

…, C Besse, V Bessi, G Binetti, A Bizarro, R Blesa… - Nature …, 2022 - nature.com
Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

Human neoteny revisited: The case of synaptic plasticity

E Bufill, J Agustí, R Blesa - American Journal of Human Biology, 2011 - Wiley Online Library
The process of learning requires morphological changes in the neuronal connections and the
formation of new synapses. Due to the importance of memory and learning in our species, …

[HTML][HTML] Alzheimer's disease in Down syndrome: An overlooked population for prevention trials

A Strydom, A Coppus, R Blesa, A Danek… - Alzheimer's & Dementia …, 2018 - Elsevier
The discovery that adults with Down syndrome (DS) have neuropathological features
identical to individuals with sporadic Alzheimer's disease (AD) played a key role in the …

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis

…, A Nordberg, JO Rinne, G Chételat, A Lleo, R Blesa… - Jama, 2015 - jamanetwork.com
Importance Amyloid-β positron emission tomography (PET) imaging allows in vivo detection
of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its …

Clinical validity of the 'mini-mental state'for Spanish speaking communities

R Blesa, M Pujol, M Aguilar, P Santacruz… - Neuropsychologia, 2001 - Elsevier
The Mini-Mental State (MMS) is a brief structured test of cognitive function. The purpose of
this study was to adapt and normalise MMS for the Spanish population. The test was …

sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

…, D Alcolea, J Fortea, A Lleó, R Blesa… - EMBO molecular …, 2016 - embopress.org
TREM 2 is an innate immune receptor expressed on the surface of microglia. Loss‐of‐function
mutations of TREM 2 are associated with increased risk of Alzheimer's disease ( AD ). …

Frontotemporal dementia and its subtypes: a genome-wide association study

…, E Scarpini, J Clarimón, A Lleó, R Blesa… - The Lancet …, 2014 - thelancet.com
Background Frontotemporal dementia (FTD) is a complex disorder characterised by a broad
range of clinical manifestations, differential pathological signatures, and genetic variability. …

Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial

P Scheltens, JWR Twisk, R Blesa… - Journal of …, 2012 - content.iospress.com
Souvenaid aims to improve synapse formation and function. An earlier study in patients with
Alzheimer’s disease (AD) showed that Souvenaid increased memory performance after 12 …

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg

…, MJ Sedano, E Gallardo, J Berciano, R Blesa… - Neurology, 2014 - AAN Enterprises
Objective: To describe the frequency of antibodies against neurofascin in chronic inflammatory
demyelinating polyradiculoneuropathy (CIDP) and the associated clinical features. …

[HTML][HTML] Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

…, D Alcolea, J Clarimón, SH Zaman, R Blesa… - The Lancet, 2020 - thelancet.com
Background Alzheimer's disease and its complications are the leading cause of death in
adults with Down syndrome. Studies have assessed Alzheimer's disease in individuals with …